Tenax Therap (TENX)
Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-10...
- Open
- 1.790
- High
- 1.850
- Low
- 1.770
- Prev. Close
- 1.840
- Volume
- 4.19M
- Turnover
- 7.56M
- Avg Price
- 1.806
- Bid/Ask Ratio
- 99.00%
- Amplitude
- 4.35%
- 52wk High
- 19.400
- Volume Ratio
- 2.41
- Turnover Ratio
- 92.90%
Tenax Therap Analyst Rating
View moreForecast & Rating
Aug 31, 2026Price forecast
$12.56597.53%
Forecast & RatingBuy
10analysts
- Strong buy50.00%
- Buy10.00%
- Hold40.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 9 hours ago
Tenax Therapeutics CEO to present at Cantor Global Healthcare Conference
- benzinga_article · 13 hours ago
5 Stocks In The Spotlight From Wall Street's Most Accurate Analysts Last Month
- benzinga_article · 1 day ago, 01:18 PM
This Sempra Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
- PUBT · Aug 29 at 12:21 PM
Tenax presents Phase 3 LEVEL data showing TNX-103 boosts 6-minute walk distance in lower baseline subgroup
- StockTitan · Aug 29 at 04:21 AM
Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 | TENX Stock News
